Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2024-06-10 Declaration of Voting R…
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC by DaVita Inc. dated June 6, 2024. The content focuses on the submission of matters to a vote of security holders at the 2024 Annual Meeting of Stockholders, including detailed voting results for director elections, ratification of the independent auditor, and advisory vote on executive compensation. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings. The document is not an Annual Report, Proxy Statement, or Management Report, but specifically reports voting outcomes. The length and detail confirm it is not a brief announcement but a full voting results report.
2024-06-10 English
Regulatory Filings 2024
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify the document as any specific filing type. According to the fallback rule, when a document does not fit any specific category or lacks sufficient information, it should be classified as a Regulatory Filing (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable. Therefore, the best classification is RNS with moderate confidence due to lack of readable content.
2024-05-31 English
FORM 4
Director's Dealing
2024-05-17 English
FORM 4
Director's Dealing
2024-05-17 English
FORM 4
Director's Dealing
2024-05-17 English
FORM 4
Director's Dealing
2024-05-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.